News stories about MINDBODY (NASDAQ:MB) have trended positive recently, Accern Sentiment reports. The research group identifies negative and positive media coverage by monitoring more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. MINDBODY earned a coverage optimism score of 0.26 on Accern’s scale. Accern also gave media headlines about the technology company an impact score of 45.6092574373395 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.

A number of equities analysts recently issued reports on MB shares. UBS Group reissued a “buy” rating and set a $40.00 price target (up previously from $34.00) on shares of MINDBODY in a report on Thursday, November 9th. BidaskClub lowered MINDBODY from a “buy” rating to a “hold” rating in a report on Friday. Zacks Investment Research lowered MINDBODY from a “buy” rating to a “hold” rating in a report on Wednesday, November 1st. Morgan Stanley raised their price target on MINDBODY from $34.00 to $37.00 and gave the stock an “equal weight” rating in a report on Tuesday, January 30th. Finally, DA Davidson started coverage on MINDBODY in a report on Wednesday, November 15th. They set a “buy” rating and a $42.00 price target on the stock. Three investment analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. The company has an average rating of “Buy” and an average target price of $33.96.

Shares of MINDBODY (NASDAQ:MB) traded down $0.45 during trading hours on Friday, reaching $30.25. 108,045 shares of the company were exchanged, compared to its average volume of 357,255. The company has a debt-to-equity ratio of 0.06, a quick ratio of 9.20 and a current ratio of 9.20. The firm has a market capitalization of $1,482.72, a P/E ratio of -79.74 and a beta of -0.08. MINDBODY has a 1 year low of $21.57 and a 1 year high of $36.25.

In other news, CEO Richard Lee Stollmeyer sold 17,739 shares of MINDBODY stock in a transaction that occurred on Friday, December 1st. The shares were sold at an average price of $31.95, for a total transaction of $566,761.05. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Brett T. White sold 10,000 shares of MINDBODY stock in a transaction that occurred on Friday, December 1st. The shares were sold at an average price of $31.94, for a total transaction of $319,400.00. The disclosure for this sale can be found here. In the last 90 days, insiders sold 92,348 shares of company stock valued at $2,883,809. 8.22% of the stock is owned by insiders.

COPYRIGHT VIOLATION NOTICE: “MINDBODY (MB) Given Coverage Optimism Rating of 0.26” was originally published by Watch List News and is the sole property of of Watch List News. If you are accessing this piece of content on another website, it was copied illegally and republished in violation of US & international copyright laws. The correct version of this piece of content can be viewed at https://www.watchlistnews.com/mindbody-mb-given-coverage-optimism-rating-of-0-26/1855681.html.

MINDBODY Company Profile

MINDBODY, Inc is a provider of cloud-based business management software for the wellness services industry and operates as a consumer marketplace with local business subscribers on its platform. The Company’s subscribers provide a range of wellness services to active consumers. Its integrated software and payments platform helps business owners in the wellness services industry run, market and build their businesses.

Insider Buying and Selling by Quarter for MINDBODY (NASDAQ:MB)

Receive News & Ratings for MINDBODY Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MINDBODY and related companies with MarketBeat.com's FREE daily email newsletter.